Becton Dickinson BDX
NYSE BDX
$192.00 +4.38 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Becton Dickinson (BDX) Cash from Financing Activities (2009 - 2026)

Becton Dickinson (BDX) posted quarterly Cash from Financing Activities of -$414.0 million for Q1 2026, down 989.47% year-over-year from $46.5 million in Q1 2025, and down 37.09% quarter-over-quarter from -$302.0 million in Q4 2025.

Becton Dickinson (BDX) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has reported Cash from Financing Activities for 18 consecutive years, with -$414.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 989.47% year-over-year to -$414.0 million; the TTM figure through Mar 2026 stood at -$2.4 billion (down 227.84% YoY), while the FY2025 annual figure was -$3.6 billion, down 273.31% from the prior year.
  • Cash from Financing Activities slipped to -$414.0 million in Q1 2026 per BDX's latest filing, from -$302.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.7 billion in Q1 2024 and bottomed at -$1.9 billion in Q4 2024.
  • Historically, Cash from Financing Activities has averaged -$271.2 million across 5 years, with a median of -$534.0 million in 2022.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 427.57% — and 2026, when it plunged 989.47%.
  • Becton Dickinson's Cash from Financing Activities stood at -$534.0 million in 2022, then slumped by 61.42% to -$862.0 million in 2023, then plunged by 123.67% to -$1.9 billion in 2024, then jumped by 84.34% to -$302.0 million in 2025, then tumbled by 37.09% to -$414.0 million in 2026.
  • Business Quant data shows BDX's Cash from Financing Activities at -$414.0 million in Q1 2026, -$302.0 million in Q4 2025, and -$809.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -287.90 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -577.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -510.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -263.16 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -159.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -164.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -300.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -75.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -31.00 Mn
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -67.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -577.00 Mn
Jun 30, 2026 -577.00 Mn
Mar 31, 2026 -414.00 Mn
Mar 31, 2026 -414.00 Mn
Dec 31, 2025 -302.00 Mn
Dec 31, 2025 -302.00 Mn
Sep 30, 2025 -809.00 Mn
Sep 30, 2025 -809.00 Mn
Jun 30, 2025 -842.00 Mn
Jun 30, 2025 -842.00 Mn
Mar 31, 2025 -38.00 Mn
Mar 31, 2025 -38.00 Mn
Dec 31, 2024 -1.93 Bn
Dec 31, 2024 -1.93 Bn
Sep 30, 2024 124.00 Mn
Sep 30, 2024 124.00 Mn
Jun 30, 2024 1.12 Bn
Jun 30, 2024 1.12 Bn
Mar 31, 2024 1.71 Bn
Mar 31, 2024 1.71 Bn